Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Cancer

Clinical trial NCT01130753 · COMPLETED

Trial details

NCT number: NCT01130753
Sponsor: Samsung Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Neoplasms Erlotinib Neoadjuvant Therapy

Start date: 2007-01-01
Primary completion: 2010-12-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.